Public Perceptions on Breast Implant–associated Anaplastic Large Cell Lymphoma
An interesting article by Lee et al., aiming to gauge the baseline knowledge and concern regarding BIA-ALCL among adult laywomen within the United States.
Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) has entered the spotlight as high-profile media outlets, and the Food and Drug Administration has begun to relay the evolving science to the public. This study aimed to gauge the baseline knowledge and concern regarding BIA-ALCL among adult laywomen within the United States. Additionally, we sought to understand the influence of variables including previous exposure to breast implants for both cosmetic and reconstructive purposes and the source of information on these outcomes.
The authors conclude that patients undergoing breast reconstruction using implants for both cosmetic and reconstructive purposes receive their information primarily from healthcare professionals or media/healthcare blogs; however, only a minority have heard of BIA-ALCL and understand the strength of the association between BIA-ALCL and implants. When provided with the most up-to-date information, patients understand the rarity of the complication and the majority are unchanged in their decision to receive breast implants. As plastic surgeons, we can promote awareness among prospective patients and reassure the anxieties of those who have previously received breast implants. Our findings suggest that professional healthcare blogs and media outlets may be the most effective way to spread knowledge to those who are not in direct contact with healthcare professionals.
Read the full article here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750521/
Or click 'Related Content' above.